SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Time for global scale-up, not randomized trials, of uterine balloon tamponade for postpartum hemorrhage.

Burke, TF; Thapa, K; Shivkumar, P; Tarimo, V; Oguttu, M; Garg, L; Pande, S; Fidvi, J; Bangal, V; Ochoa, J; et al. Burke, TF; Thapa, K; Shivkumar, P; Tarimo, V; Oguttu, M; Garg, L; Pande, S; Fidvi, J; Bangal, V; Ochoa, J; Amatya, A; Eckardt, M; Horo, A; Rogo, K; Kedar, K; Manasyan, A; Khalatkar, P; Ku, S; Seim, A; Suarez, S; Guha, M; Abdalla, K; Fuchtner, C; Escobar, MF; Arulkumaran, S (2018) Time for global scale-up, not randomized trials, of uterine balloon tamponade for postpartum hemorrhage. Int J Gynaecol Obstet, 142 (1). pp. 115-118. ISSN 1879-3479 https://doi.org/10.1002/ijgo.12492
SGUL Authors: Arulkumaran, Sabaratnam

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (178kB) | Preview

Abstract

Maternal death is the greatest health disparity globally, with postpartum hemorrhage the most common cause. As senior leaders in obstetrics and maternal health from Bolivia, Canada, Colombia, Côte d'Ivoire, Honduras, India, Kenya, Nepal, Niger, Norway, Peru, Tanzania, the UK, the USA, and Zambia, we are deeply disturbed by recent calls for randomized controlled trials (RCTs) of uterine balloon tamponade (UBT) in women with uncontrolled postpartum hemorrhage (PPH). Our collective experience, in combination with mounting evidence, unequivocally supports the effectiveness of commercial and condom UBTs in averting death and disability from PPH associated with atonic uterus. We believe it would be highly unethical to embark on an RCT of UBT, now or in the future, unless compared with a proven equivalent intervention. This article is protected by copyright. All rights reserved.

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Burke, T. F., Thapa, K. , Shivkumar, P. , Tarimo, V. , Oguttu, M. , Garg, L. , Pande, S. , Fidvi, J. , Bangal, V. , Ochoa, J. , Amatya, A. , Eckardt, M. , Horo, A. , Rogo, K. , Kedar, K. , Manasyan, A. , Khalatkar, P. , Ku, S. , Seim, A. , Suarez, S. , Guha, M. , Abdalla, K. , Fuchtner, C. , Escobar, M. F. and Arulkumaran, S. (2018), Time for global scale‐up, not randomized trials, of uterine balloon tamponade for postpartum hemorrhage. Int J Gynecol Obstet, 142: 115-118, which has been published in final form at https://doi.org/10.1002/ijgo.12492. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: Clinical equipoise, Global scale-up, Low-resource settings, Maternal mortality, Postpartum hemorrhage, Randomized controlled trial, Uterine balloon tamponade
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Int J Gynaecol Obstet
ISSN: 1879-3479
Language: eng
Dates:
DateEvent
5 June 2018Published
14 April 2018Published Online
22 March 2018Accepted
Publisher License: Publisher's own licence
PubMed ID: 29569396
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109696
Publisher's version: https://doi.org/10.1002/ijgo.12492

Actions (login required)

Edit Item Edit Item